[{"address1": "3805 Old Easton Road", "city": "Doylestown", "state": "PA", "zip": "18902", "country": "United States", "phone": "(215) 948-4119", "website": "https://aprea.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers; and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Oren  Gilad Ph.D.", "age": 56, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 575490, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John P. Hamill CPA", "age": 60, "title": "Senior VP, CFO, Principal Accounting Officer & Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 444280, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lars B. Abrahmsen Ph.D.", "age": 67, "title": "Senior VP & Chief Scientific Officer", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Wiley", "age": 56, "title": "Senior Vice President of Corporate Development & Strategy", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michel  Afargan Ph.D.", "title": "Head of Pharmacology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ze'ev  Weiss B.Sc., C.P.A.", "age": 62, "title": "Chief Business Advisor", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Epstein", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 7, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1756684800, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.5, "open": 1.53, "dayLow": 1.43, "dayHigh": 1.53, "regularMarketPreviousClose": 1.5, "regularMarketOpen": 1.53, "regularMarketDayLow": 1.43, "regularMarketDayHigh": 1.53, "payoutRatio": 0.0, "beta": 1.58, "forwardPE": -1.4117647, "volume": 44841, "regularMarketVolume": 44841, "averageVolume": 53588, "averageVolume10days": 35920, "averageDailyVolume10Day": 35920, "bid": 0.0, "ask": 1.53, "bidSize": 0, "askSize": 1, "marketCap": 8388376, "fiftyTwoWeekLow": 1.412, "fiftyTwoWeekHigh": 5.01, "priceToSalesTrailing12Months": 9.974146, "fiftyDayAverage": 1.65542, "twoHundredDayAverage": 2.28771, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -7416462, "profitMargins": 0.0, "floatShares": 4635801, "sharesOutstanding": 5825261, "sharesShort": 84496, "sharesShortPriorMonth": 56425, "sharesShortPreviousMonthDate": 1753920000, "dateShortInterest": 1756425600, "sharesPercentSharesOut": 0.0145000005, "heldPercentInsiders": 0.11304, "heldPercentInstitutions": 0.31195, "shortRatio": 1.6, "shortPercentOfFloat": 0.0163, "impliedSharesOutstanding": 5825261, "bookValue": 2.332, "priceToBook": 0.6174957, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -13850097, "trailingEps": -2.3, "forwardEps": -1.02, "lastSplitFactor": "1:20", "lastSplitDate": 1676246400, "enterpriseToRevenue": -8.818, "enterpriseToEbitda": 0.502, "52WeekChange": -0.5294118, "SandP52WeekChange": 0.1653893, "quoteType": "EQUITY", "currentPrice": 1.44, "targetHighPrice": 11.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.5, "targetMedianPrice": 10.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 16532199, "totalCashPerShare": 2.838, "ebitda": -14774702, "totalDebt": 0, "quickRatio": 5.219, "currentRatio": 5.344, "totalRevenue": 841012, "revenuePerShare": 0.14, "returnOnAssets": -0.39124, "returnOnEquity": -0.67541003, "grossProfits": -8759752, "freeCashflow": -8152045, "operatingCashflow": -12741123, "revenueGrowth": -0.79, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -28.682959, "financialCurrency": "USD", "symbol": "APRE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "Aprea Therapeutics, Inc.", "longName": "Aprea Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1570109400000, "postMarketChangePercent": 0.69444376, "postMarketPrice": 1.45, "postMarketChange": 0.00999999, "regularMarketChange": -0.0599999, "regularMarketDayRange": "1.43 - 1.53", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 53588, "fiftyTwoWeekLowChange": 0.028000116, "fiftyTwoWeekLowChangePercent": 0.019830111, "fiftyTwoWeekRange": "1.412 - 5.01", "fiftyTwoWeekHighChange": -3.5700002, "fiftyTwoWeekHighChangePercent": -0.71257484, "fiftyTwoWeekChangePercent": -52.941177, "earningsTimestampStart": 1754915400, "earningsTimestampEnd": 1755261000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.3, "epsForward": -1.02, "epsCurrentYear": -0.67, "priceEpsCurrentYear": -2.1492538, "corporateActions": [], "postMarketTime": 1758324583, "regularMarketTime": 1758312003, "exchange": "NCM", "messageBoardId": "finmb_329831339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.0, "regularMarketPrice": 1.44, "fiftyDayAverageChange": -0.21541989, "fiftyDayAverageChangePercent": -0.13013005, "twoHundredDayAverageChange": -0.8477099, "twoHundredDayAverageChangePercent": -0.37054956, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Aprea Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-09-20"}]